The US private capital group is paying $6 bln for half of the Danish group's big UK renewables project. Orsted gets cash to help avert a credit downgrade. But Apollo’s right to 70% of the wind farm's ...

The Spanish group’s new plan involves a 50% dividend cut to trim leverage and fund investments. Yet its targets are modest, and the upside from M&A and a cybersecurity push is still uncertain. A 10% ...

Over 120 countries now have self-imposed fiscal straitjackets, up 7% since Covid. Britain, whose finance minister Rachel ...

The US coffee giant is selling control of its mainland retail operations to Boyu Capital in a $4 bln deal, even though it ...

Izzy Englander sold 15% of his sprawling hedge fund at a $14 bln valuation. With $79 bln in assets, that price implies slower growth even as the industry raises record sums of capital. The architect ...

Kleenex maker Kimberly-Clark will buy Kenvue at a 46% premium, tanking its own stock by 13%. Synergies promise a decent return to numb the pain of a high price. It’s an opportunistic bet that claims ...

The US pharma giant wants a court to stop biotech Metsera from ditching its deal for an $8.5 bln rival bid from Novo Nordisk. The Danish giant's cash comes with few strings, making the legal approach ...

CEO Simon Trott still has time to intervene in his London-listed rival's nil-premium offer for the $21 bln Canadian miner. Stepping in with a higher bid may work, and the returns could stack up. A ...

Brussels wants to coordinate a defensive shield of unmanned aerial vehicles by 2027. Its approach is bureaucratic and slow. A ...